CYTK
Cytokinetics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
CYTK fundamentals
Cytokinetics (CYTK) released its earnings on Nov 5, 2025: revenue was 1.93M (YoY +316.85%), missed estimates; EPS was -2.55 (YoY -87.50%), missed estimates.
Revenue / YoY
1.93M
+316.85%
EPS / YoY
-2.55
-87.50%
Report date
Nov 5, 2025
CYTK Earnings Call Summary for Q3,2025
- FDA Approval Momentum: Aficamten on track for U.S. approval in December 2025, with EU decision expected H1 2026 and China filing via Sanofi partnership.
- Clinical Differentiation: MAPLE-HCM demonstrated aficamten superiority vs. metoprolol, with 15% YoY revenue growth and 5% operating expense decline.
- Commercial Readiness: 20+ year experienced sales team, patient navigator program, and REMS-aligned launch strategy for rapid HCP engagement.
- Financial Strength: $1.25 billion cash balance, $327M convertible notes, and $100M Royalty Pharma loan support 2025-2026 launch and pipeline advancement.
- Pipeline Progress: ACACIA-HCM readout Q2 2026, COMET-HF enrollment ongoing, and AMBER-HFpEF progressing toward 2026 data.
EPS
Revenue
Revenue & Expenses
CYTK has released its 2025 Q3 earnings report, with revenue of 1.94M, reflecting a YoY change of 318.14%, and net profit of -306.18M, showing a YoY change of -90.71%. The Sankey diagram below clearly presents CYTK's revenue sources and cost distribution.
Key Indicators
Cytokinetics (CYTK) key financial stats and ratios, covering profitability, financial health, and leverage.
Cytokinetics (CYTK)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Cytokinetics (CYTK)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cytokinetics (CYTK)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Cytokinetics (CYTK) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Cytokinetics (CYTK) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What does Cytokinetics do and what are its main business segments?What factors drove the changes in Cytokinetics's revenue and profit?What is Cytokinetics's gross profit margin?What were the key takeaways from Cytokinetics’s earnings call?What were the key takeaways from Cytokinetics's earnings call?What is Cytokinetics's latest dividend and current dividend yield?What is the revenue and EPS growth rate for Cytokinetics year over year?Did Cytokinetics beat or miss consensus estimates last quarter?
